Osmotica Pharmaceutical Corp.
Mark Foley is currently the Vice President of Pharmaceutical Sciences at Osmotica Pharmaceutical Corp. Prior to this role, Mark has held various senior leadership positions in pharmaceutical companies such as Teva Pharmaceuticals, Qualitest Pharmaceuticals, and Celgene. With over three decades of experience in the pharmaceutical industry, Mark has demonstrated expertise in areas such as technology transfer, validation, process troubleshooting, and optimization. Mark holds an MBA in Finance from the University of Missouri-Kansas City and a BA in Chemistry and Psychology from William Jewell College. Mark's experience and leadership have been instrumental in the successful operations of various pharmaceutical companies throughout their career.
This person is not in any offices
Osmotica Pharmaceutical Corp.
Osmotica Pharmaceutical is a fully-integrated pharmaceutical company with demonstrated expertise in developing commercially successful products. As one of the world's leading osmotic drug delivery companies, we leverage our significant resources in R&D and proprietary drug delivery technology to address the growing need of the global patient population. We have the resources and experience to successfully commercialize our products through our subsidiaries, Vertical Pharmaceuticals, LLC and Trigen Laboratories, LLC. For more company information, please visit our websites: www.Osmotica.com www.VerticalPharma.com www.TrigenLab.com